Geir F. Oy
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential.
Journal: Communications medicine
Published: August 25, 2025
Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: May 26, 2025
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses.
Journal: Frontiers in oncology
Published: September 09, 2022
Liver X receptors induce antiproliferative effects in basal-like breast cancer.
Journal: Molecular oncology
Published: June 28, 2022
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.
Journal: British journal of cancer
Published: February 22, 2022
Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model.
Journal: Biomacromolecules
Published: September 20, 2021
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft.
Journal: Nanomaterials (Basel, Switzerland)
Published: April 07, 2021
Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.
Journal: Scientific reports
Published: September 22, 2020
Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes.
Journal: Cancers
Published: May 25, 2020
MX 2 is a novel regulator of cell cycle in melanoma cells.
Journal: Pigment cell & melanoma research
Published: July 08, 2019
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma.
Journal: Molecular cancer therapeutics
Published: March 19, 2019
Last Updated: 09/26/2026